Choose language

en
  • cs

  • de

  • el

  • en

  • es

  • et

  • fr

  • it

  • kk

  • lt

  • nl

  • pl

  • pt

  • ro

  • ru

  • uk

English
  • Čeština

  • Deutsch

  • ελληνική

  • English

  • Español

  • Eesti keel

  • Français

  • Italiano

  • Казақша

  • Lietuvių

  • Nederlands

  • Polski

  • Português

  • Română

  • Русский

  • Українська

How do you prefer to top up your account?

* We don't charge any commission for making deposits into your account

Vor Biopharma

IPO has ended 03.02.2021

IPO return for 3 months

31 %

IPO date

03.02.2021

Price after Lock up

$ 23.58

IPO price

$ 18.00

End of Lock up

11.05.2021

Interested in an IPO? Register and receive information by email.

Financial indicators

Profit -
EBIT -
Net profit -
Net debt -

About Company

Vor Biopharma is a US company working on R&D for innovative cancer treatment using hematopoietic stem cells (HSC's). This technology enables selectively affecting cancer cells without touching the healthy ones. Overall, the company has three R&D programs, one being at stage 1/2 of the clinical trials.

Since its inception, the company raised $152M, the major stakeholders being RA Capital Healthcare Fund, 5AM Ventures VI, PureTech Health LLC, FMR, and others.


Vor Biopharma IPO: Key Facts:

● Yield Potential: 34%
● IPO Date: February 4
● Exchange: NASDAQ (trading as VOR)
● IPO Size: $150M
● Starting Price: $16.00 to $18.00
● Underwriters: Goldman Sachs, Evercore ISI, Barclays, Stifel
● Market Cap: $588M
● Earnings in 9 mon. 2020: 0
● EBIT in 9 mon. 2020: -$28M
● Net Profit in 9 mon. 2020: -$28M
● Net Debt in 9 mon. 2020: 0


You can find Vor Biopharma Security Security Issue Memo on the SEC website.

You can apply to trade Vor Biopharma IPO before February 3, 6:00 pm UTC+2. In order to trade, you need an investment account with Freedom Finance. The minimum investment amount is $2,000, the lock up being 93 days.

As there is a huge number of people willing to invest into IPO's, you may receive shares worth a smaller amount than you specified in your order. Learn how to increase your allocation and get more IPO shares here.



Please register to buy shares Vor Biopharma

No fees for the first 30 days from the account opening date!

For EU residents only


  • Commission, per share 0 €
  • Payment by card 0.00 %
Required field
Required field